171 related articles for article (PubMed ID: 12937225)
1. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schönlein nephritis.
Rauta V; Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Nephrol Dial Transplant; 2003 Sep; 18(9):1785-91. PubMed ID: 12937225
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphism in IL-1 receptor antagonist affects its production by monocytes in IgA nephropathy and Henoch-Schonlein nephritis.
Liu Z; Yang J; Chen Z; Gong R; Li L
Chin Med J (Engl); 2001 Dec; 114(12):1313-6. PubMed ID: 11793861
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?
Liu ZH; Cheng ZH; Yu YS; Tang Z; Li LS
Kidney Int; 1997 Jun; 51(6):1938-42. PubMed ID: 9186886
[TBL] [Abstract][Full Text] [Related]
5. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
[TBL] [Abstract][Full Text] [Related]
6. Does increased urinary interleukin-1 receptor antagonist/interleukin-1beta ratio indicate good prognosis in renal transplant recipients?
Teppo AM; Honkanen E; Ahonen J; Grönhagen-Riska C
Transplantation; 1998 Oct; 66(8):1009-14. PubMed ID: 9808484
[TBL] [Abstract][Full Text] [Related]
7. [Urinary fibronectin excretion as a marker of disease activity in children with IgA nephropathy and Henoch-Schönlein nephropathy].
Roszkowska-Blaim M; Mizerska-Wasiak M; Bartłomiejczyk I
Przegl Lek; 2006; 63 Suppl 3():90-3. PubMed ID: 16898499
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
Edström Halling S; Söderberg MP; Berg UB
Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the cytokine genes and IgA nephropathy.
Syrjänen J; Hurme M; Lehtimäki T; Mustonen J; Pasternack A
Kidney Int; 2002 Mar; 61(3):1079-85. PubMed ID: 11849463
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory arterial stiffness index, blood pressure variability, and nocturnal blood pressure dip in children with IgA and Henoch-Schönlein nephropathy
.
Skrzypczyk P; Mizerska-Wasiak M; Jerszow B; Ruszczykowski P; Pańczyk-Tomaszewska M
Clin Nephrol; 2017 Jun; 87(6):301-309. PubMed ID: 28406083
[TBL] [Abstract][Full Text] [Related]
11. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
[TBL] [Abstract][Full Text] [Related]
12. Pattern of renal beta 1(alpha 1-alpha 6) integrins distribution in IgA nephropathy and Henoch-Schoenlein nephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(2):51-7. PubMed ID: 12140867
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice.
Chen A; Sheu LF; Chou WY; Tsai SC; Chang DM; Liang SC; Lin FG; Lee WH
Am J Kidney Dis; 1997 Nov; 30(5):693-702. PubMed ID: 9370186
[TBL] [Abstract][Full Text] [Related]
14. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
[TBL] [Abstract][Full Text] [Related]
15. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of clinicopathological findings and outcome of Henoch-Schonlein nephritis and IgA nephropathy in adults].
Li YT; Lv JC; Li GT; Jiang L; Song YH; Zhang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):458-61. PubMed ID: 17940559
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schönlein nephritis.
Ogura Y; Suzuki S; Shirakawa T; Masuda M; Nakamura H; Iijima K; Yoshikawa N
Am J Kidney Dis; 2000 Jul; 36(1):47-52. PubMed ID: 10873871
[TBL] [Abstract][Full Text] [Related]
18. Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis.
Delanghe SE; Speeckaert MM; Segers H; Desmet K; Vande Walle J; Laecke SV; Vanholder R; Delanghe JR
Clin Biochem; 2013 May; 46(7-8):591-7. PubMed ID: 23384534
[TBL] [Abstract][Full Text] [Related]
19. Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.
Galla JH; Spotswood MF; Harrison LA; Mestecky J
J Clin Immunol; 1985 Sep; 5(5):298-306. PubMed ID: 4055989
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
